These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 30107350)

  • 1. Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting.
    Sinyor M; Williams M; Belo S; Orser B; Vincent M; Mah L; Zarate C; Castel S; Levitt AJ; Schaffer A
    J Affect Disord; 2018 Dec; 241():103-109. PubMed ID: 30107350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
    DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
    J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
    Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS
    Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychopharmacol; 2019 Apr; 33(4):494-501. PubMed ID: 30789302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.
    Zhou Y; Lan X; Wang C; Zhang F; Liu H; Fu L; Li W; Ye Y; Hu Z; Chao Z; Ning Y
    J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):507-518. PubMed ID: 37414272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation.
    Zhan Y; Zhang B; Zhou Y; Zheng W; Liu W; Wang C; Li H; Chen L; Yu L; Walter M; Li M; Li MD; Ning Y
    J Affect Disord; 2019 May; 251():205-212. PubMed ID: 30927581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study.
    Feeney A; Hock RS; Freeman MP; Flynn M; Hoeppner B; Iosifescu DV; Trivedi MH; Sanacora G; Mathew SJ; Debattista C; Ionescu DF; Fava M; Papakostas GI
    Eur Neuropsychopharmacol; 2021 Aug; 49():122-132. PubMed ID: 34090255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the course of suicidal ideation response to ketamine.
    Ballard ED; Yarrington JS; Farmer CA; Richards E; Machado-Vieira R; Kadriu B; Niciu MJ; Yuan P; Park L; Zarate CA
    J Affect Disord; 2018 Dec; 241():86-93. PubMed ID: 30099268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions.
    Zheng W; Gu LM; Yang XH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    Int J Psychiatry Clin Pract; 2023 Jun; 27(2):145-150. PubMed ID: 36309806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
    Phillips JL; Norris S; Talbot J; Hatchard T; Ortiz A; Birmingham M; Owoeye O; Batten LA; Blier P
    Neuropsychopharmacology; 2020 Mar; 45(4):606-612. PubMed ID: 31759333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
    Wilkinson ST; Ballard ED; Bloch MH; Mathew SJ; Murrough JW; Feder A; Sos P; Wang G; Zarate CA; Sanacora G
    Am J Psychiatry; 2018 Feb; 175(2):150-158. PubMed ID: 28969441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.
    Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ
    Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients.
    Chen X; Wang M; Hu Y; Zhan Y; Zhou Y; Zheng W; Liu W; Wang C; Zhong X; Li H; Lan X; Ning Y; Zhang B
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):431-438. PubMed ID: 33386430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.
    Zolghadriha A; Anjomshoaa A; Jamshidi MR; Taherkhani F
    BMC Psychiatry; 2024 May; 24(1):341. PubMed ID: 38714931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of melancholic features on positive and negative suicidal ideation in patients with treatment-resistant depression and strong suicidal ideation receiving low-dose ketamine infusion.
    Chen MH; Su TP; Li CT; Lin WC; Wu HJ; Tsai SJ; Bai YM; Mao WC; Tu PC
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):759-766. PubMed ID: 38052767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder.
    Vande Voort JL; Ballard ED; Luckenbaugh DA; Bernert RA; Richards EM; Niciu MJ; Park LT; Machado-Vieira R; Duncan WC; Zarate CA
    J Clin Psychiatry; 2017; 78(8):1068-1074. PubMed ID: 27929610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.